Hsp90i resistance - Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors

ABSTRACT: The goal is to describe the mechanisms underlying the resistance of melanoma against Hsp90i using (phospho)proteomics

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Gianluca Maddalo  

LAB HEAD: Mathias Uhlen

PROVIDER: PXD005518 | Pride | 2018-02-26

REPOSITORIES: Pride